S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
NASDAQ:ADXS

Ayala Pharmaceuticals (ADXS) Stock Forecast, Price & News

$0.85
-0.14 (-14.14%)
(As of 05/26/2023 ET)
Compare
Today's Range
$0.85
▼
$1.18
50-Day Range
N/A
52-Week Range
$0.65
▼
$7.20
Volume
15,594 shs
Average Volume
9,756 shs
Market Capitalization
$1.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsSocial Media

About Ayala Pharmaceuticals

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Company Calendar

Today
5/27/2023
Fiscal Year End
10/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADXS
CUSIP
N/A
CIK
N/A
Web
www.ayalapharma.com
Phone
(609) 452-9813
Fax
609-452-9818
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($8.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,360,000.00
Net Margins
N/A
Pretax Margin
-578,049.94%
Return on Equity
-125.27%
Return on Assets
-89.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.86
Quick Ratio
11.18

Sales & Book Value

Annual Sales
$250,000.00
Price / Sales
6.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.33 per share
Price / Book
0.16

Miscellaneous

Outstanding Shares
1,820,000
Free Float
1,810,000
Market Cap
$1.55 million
Optionable
Not Optionable
Beta
2.44

Key Executives

  • Ken Berlin
    President, Chief Executive Officer & Director
  • Igor Gitelman
    VP-Finance, Chief Financial & Accounting Officer
  • Andres A. Gutiérrez
    Chief Medical Officer & Executive Vice President
  • Michael Grace
    Vice President-Technical Operations

Key Competitors

View All Competitors













ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2023?

Ayala Pharmaceuticals' stock was trading at $0.99 at the start of the year. Since then, ADXS shares have decreased by 14.1% and is now trading at $0.85.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Ayala Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Anavex Life Sciences (AVXL), VistaGen Therapeutics (VTGN), Novavax (NVAX), Highpower International (HPJ), OPKO Health (OPK) and Athersys (ATHX).

What is Ayala Pharmaceuticals' stock symbol?

Ayala Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADXS."

How do I buy shares of Ayala Pharmaceuticals?

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ayala Pharmaceuticals' stock price today?

One share of ADXS stock can currently be purchased for approximately $0.85.

How much money does Ayala Pharmaceuticals make?

Ayala Pharmaceuticals (NASDAQ:ADXS) has a market capitalization of $1.55 million and generates $250,000.00 in revenue each year. The company earns $-14,360,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis.

How can I contact Ayala Pharmaceuticals?

Ayala Pharmaceuticals' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.ayalapharma.com. The company can be reached via phone at (609) 452-9813, via email at ir@ayalapharma.com, or via fax at 609-452-9818.

This page (NASDAQ:ADXS) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -